
151327 Brady Corporation | Computer Equipment | DigiKey
Order Brady Corporation 151327 (2267-151327-ND) at DigiKey. Check stock and pricing, view product specifications, and order online.
Item # 151327, INS 25/M6 /10 EK On SPIROL
SPIROL’s Series 25 Tapered Inserts are designed for tapered holes with an 8° (included) draft angle and are installed with heat or ultrasonic vibration. The Series 25 Inserts are similar to the Series 24 Inserts with the addition of a head for increased bearing area.
手机前六位号码:151327 | 查号吧
151327是前六位手机号码,下面是以151327开头的七位号段列表,包括该号段归属城市、运营商名称等信息。 1513270 ,归属省份地区: 河北 、 沧州 ,电信运营商: 移动 ,手机卡类型: 151 卡
151327 Brady Corporation | 计算机设备 | DigiKey - 得捷电子 ...
在 DigiKey 订购 Brady Corporation 151327 (2267-151327-ND)。了解库存和定价,查看产品技术规格,然后在线订购。
ALF14 Adapter for Yamaha iPulse M10 M20 F2 Feeder - Brady Part: 151327 ...
Make PCB ID a breeze with the ALF14-25 Label Feeder. This automatic label feeder is customizable so you can use it with a variety of pick and apply machines. Part: 151327
Organic thiophosphate WR-151327 suppresses expression of HIV …
Reducing agents such as glutathione (GSH), glutathione ester (GSE), and N-acetylcysteine (NAC) have been shown to suppress the induction of HIV expression in chronically infected cells stimulated by cytokines. We present data which show the effects of the organic thiophosphate WR-151327 on the expre …
2,5-Dimethyl-3-pyrroline, mixture of cis and trans - MilliporeSigma
2,5-Dimethyl-3-pyrroline was used in the synthesis of pyrolyzed M–N x /C ORR catalyst [1]. Don't see the Right Version? If you require a particular version, you can look up a specific certificate …
(WR 151327) - 药物靶点:Reactive oxygen species_专利_临床_研发
WR 151327: 一种Reactive oxygen species scavengers药物,由Walter Reed Army Institute of Research (沃尔特里德陆军研究所)公司最早进行研发,目前全球最高研发状态为终止,作用机制: Reactive oxygen species scavengers,治疗领域: 免疫系统疾病,感染,血液及淋巴系统疾病。
WR-151327的临床前评估:口服活性化疗保护剂。,Cancer …
单次口服剂量wr-151327的预处理与ip wr-2721一样有效,可预防丝裂霉素c,顺二氨二氯二铂(ii)和顺二氨二环(环丁烷二羧基铂)白金(p388)的骨髓毒性和致死性维持抗肿瘤活性。
Preclinical Evaluation of WR-151327: An Orally Active …
1994年2月1日 · Pretreatment with a single p.o. dose of WR-151327 was as effective as i.p. WR-2721 in protecting against the myelotoxicity and lethality of mitomycin C, cis-diamminedichloroplatinum (II), and cis-diammine(cyclobutanedicarboxylato)platinum (II), while P388 antitumor activity was maintained. These data support the clinical development of WR ...